GlassScriptPhysician profile
Aaron I Benson
NPI 1164508453
$7,393.59
in general payments reported to CMS, 2019-2025
36 companies · $2,386 in 2025
The $2,386 reported for 2025 was more than what 83% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $188 · 2021: $408 · 2022: $567 · 2023: $1,294 · 2024: $2,284 · 2025: $2,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,791 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,791.14 |
| Education | $172.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,004.22 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $1,230.68 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $1,122.53 | 2020-2025 | Stelara, Tremfya |
| Regeneron Healthcare Solutions, INC. | $310.86 | 2022-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $263.91 | 2019-2025 | Xifaxan, Plenvu |
| Gilead Sciences, INC. | $245.53 | 2019-2025 | |
| Pfizer INC. | $208.46 | 2024-2025 | |
| Qol Medical, LLC | $193.73 | 2024-2025 | Sucraid, Sucraid |
| Genzyme Corporation | $186.72 | 2022-2025 | |
| Conmed Corporation | $136.34 | 2024 | Conmed Biliary |
| Lilly USA, LLC | $123.61 | 2024-2025 | Omvoh |
| Endogastric Solutions, INC | $121.04 | 2022 | |
| Phathom Pharmaceuticals, INC. | $104.44 | 2024-2025 | Voquezna |
| Creo Medical INC. | $100.00 | 2024 | Speedboat Ultraslim (Sb1l) |
| Celltrion USA INC. | $98.28 | 2024-2025 | Vegzelma |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $94.64 | 2023-2024 | Zeposia |
| Sandoz INC. | $86.37 | 2024-2025 | Hyrimoz |
| Laborie Medical Technologies Corp. | $83.34 | 2023 | |
| Intercept Pharmaceuticals, INC. | $80.51 | 2021-2023 | Ocaliva |
| Madrigal Pharmaceuticals | $69.17 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Ipsen Biopharmaceuticals, INC | $65.19 | 2025 | Iqirvo |
| Ucb, INC. | $54.37 | 2019 | |
| Braintree Laboratories, INC. | $46.38 | 2020-2024 | Sutab, Suflave |
| Vivus LLC | $39.60 | 2025 | Qsymia |
| Ferring Pharmaceuticals INC. | $36.79 | 2023 | Rebyota |
| Cook Medical LLC | $35.71 | 2023 | Hemospray |
| Biocon Biologics INC | $29.63 | 2025 | Yesintek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.45 | 2023 | Cyltezo |
| Advanced Bionics, LLC | $23.20 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Ardelyx, INC. | $21.44 | 2025 | Ibsrela |
| Organon LLC | $18.57 | 2023 | Renflexis |
| Exact Sciences Corporation | $18.42 | 2023 | Cologuard Collection Kit |
| Concordia Pharmaceuticals INC. | $16.38 | 2019 | |
| Merck Sharp & Dohme LLC | $15.06 | 2019 | |
| Allergan, INC. | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.